advertisement

Topcon

Vallée JN 11

Showing records 1 to 11 | Display all abstracts from Vallée JN

92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Vallée A
International journal of molecular sciences 2021; 22:
92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée A
Biomedicines 2021; 9:
92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Vallée A
International journal of molecular sciences 2021; 22:
92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée A
Biomedicines 2021; 9:
92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Lecarpentier Y
International journal of molecular sciences 2021; 22:
92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée JN
Biomedicines 2021; 9:
92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Lecarpentier Y
International journal of molecular sciences 2021; 22:
92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée JN
Biomedicines 2021; 9:
92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Vallée JN
International journal of molecular sciences 2021; 22:
92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Lecarpentier Y; Lecarpentier Y
Biomedicines 2021; 9:
92031 Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Vallée JN
International journal of molecular sciences 2021; 22:

Issue 22-1

Change Issue


advertisement

Oculus